Habekacin


Indications and Reactions:

Role Indications Reactions
Secondary
Pneumonia Aspiration 19.1%
Staphylococcal Infection 19.1%
Endocarditis 12.8%
Pneumonia 7.4%
Prophylaxis Against Graft Versus Host Disease 5.3%
Sepsis 5.3%
Stem Cell Transplant 4.3%
Depression 3.2%
Eating Disorder 3.2%
Infection 3.2%
Pneumonia Staphylococcal 3.2%
Bronchopulmonary Aspergillosis 2.1%
Cardiac Failure Congestive 2.1%
Cord Blood Transplant Therapy 2.1%
Febrile Neutropenia 2.1%
Deep Vein Thrombosis 1.1%
Enterococcal Bacteraemia 1.1%
Enterococcal Sepsis 1.1%
Hiccups 1.1%
Leukaemia 1.1%
Pancytopenia 25.0%
Interstitial Lung Disease 12.5%
International Normalised Ratio Increased 8.3%
Renal Failure Acute 8.3%
Alveolitis Allergic 4.2%
Febrile Neutropenia 4.2%
Hypogeusia 4.2%
Infection 4.2%
Platelet Count Decreased 4.2%
Pneumonia 4.2%
Pyrexia 4.2%
Renal Disorder 4.2%
Renal Impairment 4.2%
Sepsis 4.2%
Thrombocytopenia 4.2%
Concomitant
Drug Use For Unknown Indication 33.4%
Product Used For Unknown Indication 11.7%
Acute Promyelocytic Leukaemia 4.9%
Prophylaxis 4.8%
Stem Cell Transplant 4.6%
Immunosuppression 4.3%
Pneumonia 4.2%
Sepsis 4.2%
Fungal Infection 3.6%
Bacterial Infection 3.1%
Nocardiosis 2.9%
Prophylaxis Against Transplant Rejection 2.5%
Staphylococcal Infection 2.5%
Acute Lymphocytic Leukaemia 2.2%
Allogenic Bone Marrow Transplantation Therapy 2.2%
Febrile Neutropenia 2.0%
Infection 2.0%
Immunosuppressant Drug Therapy 1.9%
Myelodysplastic Syndrome 1.5%
Parkinson's Disease 1.5%
Pneumonia 11.0%
Sepsis 11.0%
Neutrophil Count Decreased 8.2%
White Blood Cell Count Decreased 6.8%
Death 5.5%
Pyrexia 5.5%
Venoocclusive Liver Disease 5.5%
Blood Sodium Decreased 4.1%
Febrile Neutropenia 4.1%
Hyperbilirubinaemia 4.1%
Liver Disorder 4.1%
Platelet Count Decreased 4.1%
Respiratory Failure 4.1%
Shock 4.1%
Thrombocytopenia 4.1%
Acute Respiratory Distress Syndrome 2.7%
Catheter Site Oedema 2.7%
Diabetes Mellitus 2.7%
Encephalitis Cytomegalovirus 2.7%
Graft Versus Host Disease 2.7%

Drug Data